Navigating the new EU Clinical Trials Regulation

Om avsnittet

In this episode, host Harriet Edwards is joined by Dr Katherine Bowen and Shalini Gupta to explore the transformative changes in the European Union's clinical trial landscape. The focus is on the transition from the Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR) and its significant impact on the regulatory environment.

Join us for an insightful discussion on how the CTR is shaping the future of clinical research in Europe and the positive impact it aims to have on patients.

Om avsnittet

Fler avsnitt

Live Biotherapeutics: Navigating the Next Frontier in Drug Development

UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025

How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?

Navigating the FDA Landscape: More Changes, and What's Next?

At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development

Navigating the New FDA Landscape: Opportunities and Challenges Ahead

From Lab to Launch – Avoiding the Pitfalls of Drug Development

Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025

How to Effectively De-Risk your IND Process

Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators